Alterations in the μ-opioid receptor (MOR) and dopamine D2 receptor (D2R) systems are associated with obesity and appetite control, and the magnitude of initial brain receptor system perturbation may predict long-term surgical weight loss outcomes. This evidence concerns the gene DRD2 and obesity due to melanocortin 4 receptor deficiency.